New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For GE;DELL;GSK;AZN;BEN;AAPL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
January 16, 2015
08:31 EDTGSKGlaxoSmithKline CEO says more IPOs like ViiV could happen, Retuers says
Subscribe for More Information
08:09 EDTAAPLApple price target raised to $123 from $120 at RBC Capital
Subscribe for More Information
06:27 EDTAAPLSamsung names Lee Don-tae as global design team leader, Korea Joongang says
Subscribe for More Information
06:25 EDTAAPLApple to open five new stores in China in next five weeks, Xinhua News reports
Subscribe for More Information
06:11 EDTAAPLEU says Amazon's tax deal with Luxembourg may violate laws, WSJ reports
Subscribe for More Information
06:11 EDTAAPLApple implied volatility of 41 at upper end of index mean range
Subscribe for More Information
06:10 EDTAAPLGlobal notebook shipments to reach 46M units in Q4, DigiTimes Research says
Subscribe for More Information
05:59 EDTAAPLIntel aims to ship 44M tablet APs in 2015, DigiTimes reports
Intel (INTC) targets shipping 44M tablet APs in 2015 to acount for one third of the non-Apple (AAPL) tablet shipments in 2015, reports DigiTimes. According to sources from tablet players, Intel expects losses from its tablet segment to narrow significant in 2016 as it acquires a leading position in the non-Apple tablet sector. Reference Link
January 15, 2015
16:01 EDTAAPLOptions Update; January 15, 2015
iPath S&P 500 VIX Short-Term Futures up 1.01 to 36.13. Option volume leaders: AAPL TSLA TWTR AMZN FB C CLF ABX SUNE according to Track Data.
15:02 EDTAAPLEarnings Preview: Jefferies refutes bear case on Intel
Subscribe for More Information
14:31 EDTGSKMylan launches generic Epivir-HBV tablets
Mylan (MYL) announced the U.S. launch of its Lamivudine Tablets, 100 mg, which is the generic version of GlaxoSmithKline's (GSK) Epivir-HBV. Mylan received final approval from the U.S. FDA for its Abbreviated New Drug Application for this product, which is indicated for the treatment of chronic hepatitis B virus infection associated with evidence of hepatitis B viral replication and active liver inflammation. Lamivudine Tablets, 100 mg, had U.S. sales of approximately $18.1M for the 12 months ending September 30, 2014, according to IMS Health. Currently, Mylan has 284 ANDAs pending FDA approval representing $109.1B in annual brand sales, according to IMS Health. Forty-four of these pending ANDAs are potential first-to-file opportunities, representing $29.3B in annual brand sales, for the 12 months ending June 30, 2014, according to IMS Health.
14:07 EDTAAPLBank of America says 800,000 customers enrolled in Apple Pay
Subscribe for More Information
13:06 EDTAAPLGoogle to stop selling Glass to individuals on January 19, WSJ reports
Subscribe for More Information
11:36 EDTAAPLChina's Xiaomi targets iPhone users with new handset model, AP says
Subscribe for More Information
11:08 EDTAAPLReport: Apple may include 2GB of faster RAM in iPhone 6s, MacRumors says
Apple may boost its internal RAM to 2GB and use "force touch" technology for its iPhone 6s, reports MacRumors. Citing a report from TechNews Taiwan, the RAM modules offer low power consumption and a significant performance increase from the 1GB used in the current iPhone 6 and iPhone 6 Plus. Reference Link
10:06 EDTAAPLApple falls, levels to watch
Subscribe for More Information
10:00 EDTAAPLOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: American Campus (ACC) downgraded to Sell from Neutral at Goldman... Apple (AAPL) downgraded to Neutral from Buy at Mizuho... Archer Daniels (ADM) downgraded to Neutral from Buy at Goldman... Barrick Gold (ABX) downgraded to Underweight from Equal Weight at Barclays... CNOOC (CEO) downgraded to Underperform from Hold at Jefferies... CSC (CSC) downgraded to Underweight from Neutral at JPMorgan... Computer Programs (CPSI) downgraded to Market Perform from Outperform at William Blair... D.R. Horton (DHI) downgraded to Neutral from Buy at UBS... DDR Corp. (DDR) downgraded to Neutral from Overweight at JPMorgan... Dominion Diamond (DDC) downgraded to Equal Weight from Overweight at Barclays... EVERTEC (EVTC) downgraded to Neutral from Overweight at JPMorgan... Education Realty (EDR) downgraded to Sell from Neutral at Goldman... Franco-Nevada (FNV) downgraded to Underweight from Equal Weight at Barclays... General Cable (BGC) downgraded to Neutral from Buy at Longbow... Green Dot (GDOT) downgraded to Neutral from Overweight at JPMorgan... Greif (GEF) downgraded to Neutral from Buy at BofA/Merrill... Grupo Simec (SIM) downgraded to Neutral from Buy at Goldman... Hecla Mining (HL) downgraded to Hold from Buy at BB&T... Host Hotels (HST) downgraded to Hold from Buy at MLV & Co.... Ingredion (INGR) downgraded to Sell from Neutral at Goldman... Insulet (PODD) downgraded to Market Perform from Outperform at Raymond James... Johnson & Johnson (JNJ) downgraded to Sell from Neutral at Goldman... Magna (MGA) downgraded to Hold from Buy at TD Securities... Molson Coors (TAP) downgraded to Neutral from Buy at Goldman... Nuverra Environmental (NES) downgraded at Roth Capital... Omnicom (OMC) downgraded to Hold from Buy at Evercore ISI... PetroChina (PTR) downgraded to Underperform from Hold at Jefferies... Philip Morris (PM) downgraded to Sell from Neutral at Goldman... Precision Castparts (PCP) downgraded to Hold from Buy at KeyBanc... Rio Tinto (RIO) downgraded to Neutral from Outperform at Macquarie... STAG Industrial (STAG) downgraded to Neutral from Overweight at JPMorgan... Silicon Laboratories (SLAB) downgraded to Equal Weight from Overweight at Barclays... Sinopec (SNP) downgraded to Underperform from Hold at Jefferies... Sky (SKYAY) downgraded to Neutral from Outperform at Exane BNP Paribas... Teledyne (TDY) downgraded to Underweight from Hold at KeyBanc... Woodward (WWD) downgraded to Underweight from Hold at KeyBanc... Xilinx (XLNX) downgraded to Equal Weight from Overweight at Barclays.
09:36 EDTAAPLActive equity options trading
Subscribe for More Information
08:36 EDTGSKOncoMed enrolls first biomarker-selected patient in Notch1 antibody Phase trial
Subscribe for More Information
08:30 EDTAAPLEU to publish details of Amazon's tax deal with Luxembourg, Reuters reports
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use